1. | purpledeedee247 | |
2. | prewittv | |
3. | hemzawi476 | |
4. | howiemas | |
5. | d4ortie |
1. | purpledeedee247 | |
2. | prewittv | |
3. | hemzawi476 | |
4. | howiemas | |
5. | d4ortie |
1. | prewittv 01/25/2018 Announces 'positive' 24-week interim results from the open-label Phase 2 proof of concept clinical trial, … |
2. | howiemas 01/26/2018 great rebound from yesterday |
3. | hemzawi476 01/26/2018 thank you for the heads up |
4. | purpledeedee247 02/26/2018 Announces further positive findings from PhaseOut DMD |
5. | purpledeedee247 03/10/2018 Summit Expands Enrolment in Phase 2 Clinical Trial to Include Planned Additional Group |
6. | purpledeedee247 01/26/2018 Good news for $SMMT? - Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit's PhaseOut DMD Clinical Trial |
7. | howiemas 03/27/2018 Summit Therapeutics Announces a Proposed Placing to Raise up to £15 Million |
8. | hemzawi476 01/25/2018 H.C. Wainwright & Co. reiterates Buy rating, $16 PT |
9. | hemzawi476 07/02/2018 Canaccord Genuity sets PT at $3 |
10. | hemzawi476 01/26/2018 YES!! |